天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

2-Oxazolidinone,4-(hydroxymethyl)-4-methyl-

化學(xué)構(gòu)造式
6629-85-2
CAS番號(hào).
6629-85-2
化學(xué)名:
別名:
英語名:
2-Oxazolidinone,4-(hydroxymethyl)-4-methyl-
英語別名:
4-(hydroxymethyl)-4-methyloxazolidin-2-one;2-Oxazolidinone,4-(hydroxymethyl)-4-methyl-;4-(Hydroxymethyl)-4-methyl-1,3-oxazolidin-2-one
CBNumber:
CB33256829
化學(xué)式:
C5H9NO3
分子量:
131.13
MOL File:
6629-85-2.mol

2-Oxazolidinone,4-(hydroxymethyl)-4-methyl- 物理性質(zhì)

安全性情報(bào)

2-Oxazolidinone,4-(hydroxymethyl)-4-methyl- 価格

メーカー 製品番號(hào) 製品説明 CAS番號(hào) 包裝 価格 更新時(shí)間 購入
Sigma-Aldrich Japan S756229 AldrichCPR
4-HYDROXYMETHYL-4-METHYL-2-OXAZOLIDINONE AldrichCPR		 6629-85-2 50MG ￥24400 2024-03-01 購入

2-Oxazolidinone,4-(hydroxymethyl)-4-methyl- 化學(xué)特性,用途語,生産方法

2-Oxazolidinone,4-(hydroxymethyl)-4-methyl- 上流と下流の製品情報(bào)

原材料

準(zhǔn)備製品

2-Oxazolidinone, 4-(bromomethyl)-4-methyl-

2-Oxazolidinone,4-(hydroxymethyl)-4-methyl- 生産企業(yè)

Global( 8)Suppliers
名前 電話番號(hào) 電子メール 國(guó)籍 製品カタログ 優(yōu)位度
Hangzhou MolCore BioPharmatech Co.,Ltd. 		+86-057181025280; +8617767106207
 sales@molcore.com China 49734 58
Nanjing SynTitan Pharmaceutical Co., Ltd. 25-57027686 17372956142
 li_lan@syntitan.com China 10000 58
Jiangsu aikang biomedical research and development co., LTD 025-66110311 13155353615
 qzhang@aikonchem.com China 15527 58
Shanghai meikai technology co., ltd 021-18721550-091 18721550091
 yangdong@pharma.com China 4121 58
Nanjing Shizhou Biology Technology Co.,Ltd 025-85560043 13675144456
 sean.lv@synzest.com China 11438 58
Beijing Famozi Pharmaceutical Technology Co., Ltd 13331045123
 2728639891@qq.com China 9952 58
Nanjing Shizhou Biology Technology Co.,Ltd --
 purchase@synzest.com China 6857 58
Guangdong Shengke Biochemical Technology Co., Ltd. 189-25112307 18925113981
 3809205144@qq.com China 10000 58
  • 6629-85-2
  • 2-Oxazolidinone,4-(hydroxymethyl)-4-methyl-
  • 4-(Hydroxymethyl)-4-methyl-1,3-oxazolidin-2-one
  • 4-(hydroxymethyl)-4-methyloxazolidin-2-one
Copyright 2017 ? ChemicalBook. All rights reserved